United States regulators have approved 2 new GlaxoSmithKline plc (ADR) (NYSE:GSK) treatments for an aggressive form of skin cancer, sending shares higher around 1%.
GlaxoSmithKline plc (ADR) (NYSE:GSK) last session’s volume of 1.88 million shares was lower than its average …
